Limited coverage drugs – terbinafine
Last updated on September 27, 2024
| Generic name | terbinafine |
| Strength | 250 mg |
| Form | tablet |
|
Criteria |
Approval period |
|---|---|
| For the treatment of severe onychomycosis PLUS functional disability PLUS positive KOH or dermatophyte culture of nail from a licensed lab |
First approval: Three months
Renewals: If required, up to three months. |
Practitioner exemptions
- None
Special notes
- Terbinafine cream is not eligible for PharmaCare coverage.